![](/img/cover-not-exists.png)
PRS40 THE IMPACT OF THE FDA'S RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS
Horowicz-Mehler, N, Sepulveda, B, White, C, Doyle, JVolume:
13
Language:
english
Journal:
Value in Health
DOI:
10.1016/S1098-3015(10)72993-4
Date:
May, 2010
File:
PDF, 68 KB
english, 2010